首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

EUROPEAN NEUROPSYCHOPHARMACOLOGY
ISSN：0924-977X

EUROPEAN NEUROPSYCHOPHARMACOLOGY

EUR NEUROPSYCHOPHARM
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：偏慢,4-8周
新锐分区：医学2区
年发文量：84
影响因子：6.7
JCR分区：Q1

基本信息

欧洲神经精神药理学是欧洲神经精神药理学学会（ECNP）的官方出版物。根据学院的使命，该杂志侧重于临床和基础科学的贡献，促进我们对大脑功能和人类行为的理解，并使之能够转化为精神病学的改进治疗和增强公共卫生影响。近年来，神经科学和基因组学的基础知识和可用的实验技术取得了令人兴奋的进展。然而，这些发现的临床转化并不迅速。该杂志旨在通过推广预期将对我们理解精神障碍的生物学基础以及治疗方法的开发和改进产生重大影响的发现来缩小这一差距，理想地为预防和康复铺平道路。
0924-977XSCIE/Scopus收录
6.7
点击查看最新影响趋势>
7.7
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学2区
CLINICAL NEUROLOGY 临床神经病学
2区
NEUROSCIENCES 神经科学
2区
PHARMACOLOGY & PHARMACY 药学
1区
PSYCHIATRY 精神病学
2区
否
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：CLINICAL NEUROLOGY
SCIE
Q1
24/286
学科：NEUROSCIENCES
SCIE
Q1
30/314
学科：PHARMACOLOGY & PHARMACY
SCIE
Q1
26/352
学科：PSYCHIATRY
SCIE
Q1
18/288
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：CLINICAL NEUROLOGY
SCIE
Q1
33/286
学科：NEUROSCIENCES
SCIE
Q1
42/314
学科：PHARMACOLOGY & PHARMACY
SCIE
Q1
30/353
学科：PSYCHIATRY
SCIE
Q1
35/288
100
84
点击查看年发文量趋势图>
1%一般偏慢,4-8周-医学-精神病学
11.9%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
75.00%46.8%2.11%
CiteScore：10.60
SJR：1.934
SNIP：1.340
学科类别分区排名百分位
大类：Medicine
小类：Psychiatry and Mental Health
Q1
35 / 580
大类：Medicine
小类：Pharmacology (medical)
Q1
19 / 275
大类：Medicine
小类：Neurology
Q1
16 / 194
大类：Medicine
小类：Neurology (clinical)
Q1
36 / 400
大类：Medicine
小类：Pharmacology
Q1
32 / 321
大类：Medicine
小类：Biological Psychiatry
Q1
6 / 54

期刊高被引文献

Cortical surface morphology in long-term cannabis users: A multi-site MRI study
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2018.11.1110
De Novo Coding Variants Are Strongly Associated with Tourette Syndrome
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.06.065
Psychopharmacological prescribing practices in pregnancy for women with severe mental illness: A multicentre study
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2018.11.1103
33: LANDSCAPE OF ALLELE-SPECIFIC OPEN CHROMATIN IN HUMAN IPSC-DIFFERENTIATED NEURONS AND IT IMPLICATION FOR MENTAL DISORDERS
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.034
54: GENETIC STUDY FOR THE NEUROPSYCHOLOGICAL FUNCTION IN ATTENTION DEFICIT HYPERACTIVITY DISORDER
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.055
SU83: COMBINATORIAL PHARMACOGENOMIC TESTING IMPROVES GENERALIZED ANXIETY DISORDER TREATMENT RESPONSE AND DECREASES BENZODIAZAPINE USE
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.272
SA14: WHOLE EXOME TRIO SEQUENCING IDENTIFIES NOVEL VARIANTS FOR AUTISM SPECTRUM DISORDER
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.086
SA35: PPD ACT, AN APP-BASED POSTPARTUM DEPRESSION GENETIC STUDY
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.107
Quantitative Genetic Analysis of Anxiety Trait In Bipolar Disorder
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.06.026
20: ANALYSIS OF A BROAD DEPRESSION PHENOTYPE IN UK BIOBANK
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.021
SA28: ASSOCIATIONS IN THE UK BIOBANK COHORT BETWEEN GENETIC RISK SCORE FOR CALCIUM VOLTAGE-GATED CHANNEL SUBUNIT ALPHA 1C (CACNA1C) POLYMORPHISMS AND BOTH MOOD DISORDER PHENOTYPES AND CHRONOTYPE PREFERENCE
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.100
SA117: ATTITUDE OF INDIAN RESEARCH PARTICIPANTS TOWARDS PRIVACY AND CONFIDENTIALITY
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.189
M16: PATHVIEW WEB: USER FRIENDLY PATHWAY VISUALIZATION AND DATA INTEGRATION
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.323
SU67: INTERACTIVE EFFECTS OF FAMILY HISTORY, POLYGENIC RISK AND AGE ON CORTICAL THICKNESS IN YOUNG PEOPLE AT HIGH GENETIC RISK OF BIPOLAR DISORDER
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.256
Education Day – Spanish Track
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.06.023
Novel Statistical Approaches For Imaging Genetics
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.06.044
M70: DETERMINING THE GENETIC OVERLAP BETWEEN TOURETTE SYNDROME (TS), OBSESSIVE COMPULSIVE DISORDER (OCD) AND OCD/TIC-RELATED TRAITS
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.377
SA31: GENETIC VARIANTS AS MODIFIERS OF THE ASSOCIATION OF BODY MASS INDEX WITH BIPOLAR DISORDER
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.103
63: TRANSCRIPTOMIC IMPUTATION ANALYSIS IN ANOREXIA NERVOSA IDENTIFIES BOTH METABOLIC AND PSYCHIATRIC AETIOLOGIES
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.064
SA3: REDUCED CORTICAL THICKNESS IN CHILDREN WITH ADHD: ROLE OF NET16 AND MATERNAL SMOKING DURING PREGNANCY
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.075
11: SYSTEMATIC RECONSTRUCTION OF AUTISM BIOLOGY WITH MULTI-LEVEL WHOLE EXOME ANALYSIS
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.012
Introduction On Psychiatric Genetics, Current Findings And Advances
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.06.024
SU82: RNA SIGNATURE OF TREATMENT RESPONSE IN FIRST-EPISODE PSYCHOSIS
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.271
5: AN INTEGRATED GENETIC-EPIGENETIC ANALYSIS OF SCHIZOPHRENIA: EVIDENCE FOR CO-LOCALIZATION OF GENETIC ASSOCIATIONS AND DIFFERENTIAL DNA METHYLATION FROM A LARGE META-ANALYSIS OF WHOLE BLOOD DNA
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.006
49: LARGE-SCALE GWAS META-ANALYSIS AND MULTI-TRAIT ANALYSIS YIELDS DOZENS OF NOVEL LOCI AND NOVEL GENETIC CORRELATES FOR GENERAL COGNITIVE ABILITY
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.050
Psychiatric Genetics In UK Biobank
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.06.070
SA85: PHARMACOGENOMICS OF METHYLPHENIDATE TREATMENT OF DANISH CHILDREN WITH ADHD
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.157
M97: TRANSCRIPTIONAL SIGNATURES OF CHILDHOOD ONSET SCHIZOPHRENIA IN HIPSC-DERIVED NPCS AND NEURONS ARE CONCORDANT WITH SIGNATURES FROM POST MORTEM ADULT BRAINS
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.404
SA60: TRANSCRIPTIONAL CHANGES IN MOUSE MODELS OF THE 15Q13.3 MICRODELETION SYNDROME
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.132
Initial Results From An Opioid Dependence Whole Exome Sequencing Study
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.06.056
M64: POLYGENIC RISK FOR ANXIETY SHAPES PATTERNS OF COMORBIDITY IN BIPOLAR DISORDER
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.371
How To Make A Million (Mdd Cases) – The Australian Contribution
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.06.113
68: VARIOUS RELATIONSHIPS BETWEEN DNA METHYLATION AND GENE EXPRESSION IN DIFFERENT TISSUES AND AGES
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.069
Psychiatric Genetics In South Africa: The Status QUO
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.06.084
SA78: GAPS: GENOMIC AGGREGATION PROJECT IN SWEDEN
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.150
SA116: A NOVEL APPROACH TO COMBINE GWAS, PGRS AND GENE-GENE INTERACTIONS IN PSYCHIATRY
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.188
M39: THE ASSOCIATION OF METHYLATION OF THE PROMOTER AND ANTIDEPRESSANTS IN TRANSCRIPTIONAL REGULATION OF THE BRAIN-DERIVED NEUROTROPHIC FACTOR EXON IV
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.346
Unfolding The Genetic Basis of ADHD
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.06.038
Novel Implications For RNA In Psychiatric Genetics
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.06.033
SA110: SHARED POLYGENIC RISK ANALYSIS OF ALCOHOLISM AND 5 MAJOR PSYCHIATRIC DISORDERS
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.182
SA114: GENETIC ETIOLOGY OF SELF-RATING OF THE EFFECTS OF ALCOHOL (SRE) SCORES IN YOUNG ADULTS
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.186
M104: EXAMINING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) INATTENTION SYMPTOMS AS ANTECEDENTS OF PSYCHOSIS RISK IN 22Q11.2 DELETION SYNDROME (22Q11.2DS)
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.411
Using Technology To Quantify The Phenomics of Depression
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.06.112
SA88: PARANOID THINKING IN HEALTHY INDIVIDUALS – ASSOCIATION WITH SCHIZOPHRENIA GENETICS?
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.160
Rare And Ultra-Rare Variants In Familial Schizophrenia - An Update From India
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.06.081
Psychiatric Genetics In Sudan: Chances and Opportunities
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.06.082
M28: MATERNAL AGE AT BIRTH IS ASSOCIATED WITH OFFSPRING LEUKOCYTE TELOMERE LENGTH IN FAMILIES WITH BIPOLAR DISORDER
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.335
M96: GENOME-WIDE DNA METHYLATION ANALYSIS IN A LONGITUDINAL COHORT OF ANTIPSYCHOTIC-NAIVE FIRST EPISODE OF PSYCHOSIS PATIENTS
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.403
SU100: SEQUENCE MOTIF AND PROTEIN DOMAIN ENRICHMENT ANALYSIS OF PSYCHIATRIC GWAS FINDINGS
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.289
SU59: EVALUATION AND CO-EXPRESSION OF MARKER GENES OF CELL TYPES IN BRAIN
来源期刊：European NeuropsychopharmacologyDOI：10.1016/j.euroneuro.2017.08.248

相关文章

Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15
NATURE REVIEWS DRUG DISCOVERY：中科院1区，生物工程与应用微生物，药学，接受率为21%
2025-10-15

期刊推荐

ACADEMIC EMERGENCY MEDICINE封面

ACADEMIC EMERGENCY MEDICINE

学科领域：医学
影响因子：3.2
中科院分区： 2区
ACADEMIC RADIOLOGY封面

ACADEMIC RADIOLOGY

学科领域：医学
影响因子：3.9
中科院分区： 2区
APPETITE封面

APPETITE

学科领域：医学
影响因子：3.8
中科院分区： 2区
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA封面

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

学科领域：医学
影响因子：3.1
中科院分区： 2区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布（新锐分区）
大类学科小类学科Top期刊综述期刊
医学2区
CLINICAL NEUROLOGY 临床神经病学
2区
NEUROSCIENCES 神经科学
2区
PHARMACOLOGY & PHARMACY 药学
1区
PSYCHIATRY 精神病学
2区
否
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学2区
CLINICAL NEUROLOGY 临床神经病学
2区
NEUROSCIENCES 神经科学
2区
PHARMACOLOGY & PHARMACY 药学
2区
PSYCHIATRY 精神病学
2区
否
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学2区
CLINICAL NEUROLOGY 临床神经病学
2区
NEUROSCIENCES 神经科学
2区
PHARMACOLOGY & PHARMACY 药学
2区
PSYCHIATRY 精神病学
2区
否
否